DermTech, Inc.
11099 N. Torrey Pines Road, Suite 100
La Jolla, CA 92037
(858) 450-4222
September 25, 2019
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | DermTech, Inc. | |
Registration Statement on Form S-3 | ||
Filed September 24, 2019 | ||
File No. 333-233918 |
Ladies and Gentlemen:
Pursuant to Rule 477 (Rule 477) under the Securities Act of 1933, as amended (the Securities Act), DermTech, Inc., a Delaware corporation (the Registrant), hereby requests that the Securities and Exchange Commission (the Commission) consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of the Registrants Registration Statement on Form S-3 filed with the Commission on September 24, 2019, File No. 333-233918, together with all exhibits thereto (collectively, the Registration Statement).
The Registrant requests withdrawal of the Registration Statement at the request of Marcum LLP, the Registrants former auditors. The Registrant has received communications from Marcum stating that Marcum did not provide its manually-signed consent and authorization for the Registrant to file the Registration Statement. The Registrant will be filing a new registration statement on Form S-3 as soon as practicable after the submission of this request. The Registrant confirms that no securities have been sold pursuant to the Registration Statement. Furthermore, the Registrant believes that the withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by paragraph (a) of Rule 477.
It is the Registrants understanding that this application for withdrawal of the Registration Statement will be deemed granted at the time filed with the Commission unless, within fifteen calendar days after such date, the Registrant receives notice from the Commission that this application will not be granted.
The Registrant requests, in accordance with Rule 457(p) under the Securities Act, that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the Registrants account to be offset against the filing fee for the filing of any future registration statement or registration statements.
If you have any questions regarding this application for withdrawal, please contact the Registrants legal counsel, Jeremy D. Glaser, Jenna Stewart or Christian Hollweg of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., at (858) 314-1500.
Sincerely,
DermTech, Inc.
By: | /s/ John Dobak | |
Name: | John Dobak, M.D. | |
Title: | Chief Executive Officer |